Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	26.01B
Revenue (ttm)	1.84B
Net Income (ttm)	304.75M
Shares Out	733.37M
EPS (ttm)	0.40
PE Ratio	93.49
Forward PE	80.08
Dividend	0.03 (0.07%)
Ex-Dividend Date	Aug 14, 2025

Volume	61,352,605
Average Volume	40,252,703
Open	34.43
Previous Close	34.42
Day's Range	33.94 - 37.86
52-Week Range	13.27 - 37.86
Beta	0.85
RSI	64.16
Earnings Date	Aug 27, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.